Papers

2

Total Citations

9

H-Index

2

About

Andriani Charpidou is a leading voice in thoracic oncology, with her research squarely focused on advancing the diagnosis and management of lung cancer. Her most impactful work centers on the integration of cutting-edge technology into clinical practice, particularly through robotic bronchoscopy. In her highly cited 2024 paper, she demonstrated how this technique offers a safer, more accurate alternative for sampling the increasing number of pulmonary nodules detected by CT scans, directly addressing a critical bottleneck in early lung cancer diagnosis. With over 7 citations in a short time, this work is already shaping procedural standards. Beyond her own research, Dr. Charpidou plays a pivotal role in synthesizing and disseminating the latest global advancements. Her 2025 summary of the Thoracic Oncology Assembly at the ERS Congress highlights her as a key figure who not only produces original research but also curates the field’s most pressing developments for the wider medical community. Her contributions are essential for bridging the gap between innovative technology and improved patient outcomes in the fight against the world’s leading cancer killer.

Research Focus

Key Achievements

2
H-Index
2
Papers
9
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Bronchoscopy in Lung Cancer Diagnosis
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: National and Kapodistrian University of Athens, Sotiria General Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago